NutraLife BioSciences, Inc. (NLBS) Research

NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in the creation, production, and distribution of a diverse range of health-oriented products. This includes nutraceuticals, dietary supplements, general wellness items, and a significant line of cannabidiol (CBD) products. The company's CBD portfolio is comprehensive, featuring cannabinoid-rich hemp oil sourced from industrial hemp, tinctures, and a variety of topical solutions like lotions and oils designed for direct skin application to alleviate pain or inflammation. Their CBD offerings also extend to face creams, massage oils, nutraceutical sprays enhanced with CBD, and specialized products for pets. In addition to its CBD range, NutraLife BioSciences also manufactures skincare items and hand sanitizers. Customers can acquire the company's products directly from its website, nutralifebiosciences.com, or through a network of private label distributors, other online retailers, and traditional brick-and-mortar stores. Established in 2010 and based in Coconut Creek, Florida, the enterprise was previously known as NutraFuels, Inc. It officially adopted its current name, NutraLife BioSciences, Inc., in March 2019.

Market snapshot

Symbol
NLBS
Price
$0.00
Market cap
$17.7K
P/E ratio
-0.00x
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Acacia Diversified Holdings, Inc. (ACCA)
  • Acorda Therapeutics, Inc. (ACORQ)
  • Hempfusion Wellness Inc. (CBDHF)
  • Advanzeon Solutions, Inc. (CHCR)
  • Diagnocure, Inc. (DGCRF)
  • Goodbody Health Limited (GDBYF)
  • NMC Health plc (NMMCF)
  • New You, Inc. (NWYU)

Recent insider activity

  • Ward Edgar — S-Sale (25000 shares) on 2018-10-12
  • Ward Edgar — S-Sale (20000 shares) on 2018-10-15
  • Ward Edgar — S-Sale (15000 shares) on 2018-10-15
  • Ward Edgar — S-Sale (50000 shares) on 2018-10-16
  • Ward Edgar — S-Sale (19000 shares) on 2018-10-17

Open NutraLife BioSciences, Inc. (NLBS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.